Risk Stratification in Arrhythmogenic Right Ventricular Cardiomyopathy

Area of Science:

• Cardiology
• Genetics
• Pathology

Background:

• Arrhythmogenic right ventricular cardiomyopathy (ARVC) is a genetic cardiac disease.
• It involves progressive myocyte loss and fibrofatty tissue replacement in the ventricles.
• ARVC leads to ventricular arrhythmias and a high risk of sudden cardiac death (SCD).

Purpose of the Study:

• To review literature on risk stratification factors in ARVC patients.
• To emphasize the importance of determining and stratifying patient risk for ventricular arrhythmia and SCD.
• To discuss the role and complications of implantable cardioverter-defibrillators (ICDs) in managing ARVC.

Main Methods:

• Literature review of studies on ARVC.
• Analysis of factors contributing to risk assessment in ARVC.
• Examination of clinical outcomes and management strategies.

Main Results:

• Identification of key factors for assessing ventricular arrhythmia and SCD risk in ARVC.
• Discussion of the benefits and risks associated with ICD implantation in ARVC patients.
• Highlighting the need for comprehensive risk stratification.

Conclusions:

• Accurate risk stratification is crucial for managing ARVC patients.
• ICDs are vital for preventing SCD but carry inherent complications.
• Further research into risk stratification factors can optimize ARVC patient care.